Evidence map›Paper›PMID 40468979›Full record

ArticleJournal of cachexia, sarcopenia and muscle2025

Transcriptomic Signature of Frailty in Older Patients With Cardiovascular Disease Undergoing Cardiac Surgery or TAVI.

Omar Baritello, Simon H Sündermann, Kristian Espinosa-Garnica, Jörg Kempfert, Markus Jähnert, Nick L Beetz, Dominik Geisel, Jasmin Gaugel, Julia Rominger, Ursula Müller-Werdan and 7 more

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Omar BaritelloDepartment of Rehabilitation Medicine, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Simon H SündermannDepartment of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
Kristian Espinosa-GarnicaDepartment of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
Jörg KempfertDepartment of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
Markus JähnertGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, Munich, Germany.
Nick L BeetzGerman Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Dominik GeiselDepartment of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Jasmin GaugelResearch Group Molecular and Clinical Life Science of Metabolic Diseases, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Julia RomingerResearch Group Molecular and Clinical Life Science of Metabolic Diseases, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Ursula Müller-WerdanDepartment of Geriatrics and Medical Gerontology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Catrin HerpichDepartment of Geriatrics and Medical Gerontology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Kristina NormanDepartment of Geriatrics and Medical Gerontology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Alexandra ChadtGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, Munich, Germany.
Hadi Al-HasaniGerman Center for Diabetes Research (DZD e.V.), München-Neuherberg, Munich, Germany.
Heinz VöllerDepartment of Rehabilitation Medicine, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Annett SalzwedelDepartment of Rehabilitation Medicine, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.
Heike VogelResearch Group Molecular and Clinical Life Science of Metabolic Diseases, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany.

Funding

European Union's Horizon Europe Research and Innovation Programme 101080465German Ministry of Education and Research (DZD) 82DZD00302German Ministry of Education and Research (DZD) 82DZD03D03
6 · The paper itself

Abstract

backgroundDeterioration of functional capacity mostly determinates frailty in older patients with cardiovascular disease (CVD). Elucidating the pathophysiological mechanisms of physical frailty is an important goal for improving functional health-related outcomes. Our objective was the determination of the transcriptomic signature of physical frailty phenotypes in older patients undergoing cardiac surgery.

methodsPatients aged ≥ 70 years, referred for elective cardiac surgery (e.g., coronary artery bypass graft) or transcatheter aortic valve implantation (TAVI) were recruited. At hospital admission, frailty was assessed based on moderately/severely impaired mobility (Timed Up and Go; ≥ 10 and ≥ 20 s), low gait speed (5-m Walk Test; ≥ 6 s) or reduced handgrip strength (male ≤ 27, female ≤ 16 kg). Muscle specimens (M. quadriceps femoris) were collected during surgery/intervention and used for total RNA isolation and sequencing. Differential gene expression analysis was performed using DESeq2 and regression analyses investigated association between frailty and gene expression levels.

resultsSixty-three patients (77.6 ± 4.3 years; 74% male) referred to cardiac surgery (n = 34, 54%) or TAVI (n = 29, 46%) were included. Overall, 43 patients (70.2%) were characterized as frail by moderately/severely impaired mobility, 19 (30.6%) by low gait speed and 19 (30.2%) by low handgrip strength. In total, 37 patients (59%) experienced ≥ 1 complication (e.g., need of transfusion, atrial fibrillation and delirium); one patient died. Based on transcriptome data, 10 overlapping genes between all physical frailty phenotypes were identified, with S100A1 showing the strongest differences in expression level (e.g., handgrip R

conclusionOur data highlight the potential role of S100A1 in the pathophysiological mechanisms of skeletal muscle impairments in older CVD patients and warrants further consideration as a target gene for physical frailty. These findings also advance our understanding of the genetic and biological factors contributing to frailty, potentially guiding future therapeutic strategies to mitigate its impact on health outcomes.

Indexed as

Cardiac Surgical ProceduresCardiovascular DiseasesFrailtyTranscatheter Aortic Valve ReplacementTranscriptomeAgedAged, 80 and overFemaleFrail ElderlyHumansMalecardiovascular diseasefrailtymuscle functionolder cardiac patientssarcopeniatranscriptomics

Identifiers

PMID40468979
PMCPMC12138287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.